Based on these data, we propose that, during obesity, reduced AT-EOS content is accompanied by decreased IL-4 levels, and this adversely affects adipocyte leptin secretion, thereby contributing to development of hyperleptinemia and leptin resistance. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.